Seoul Pharma Co., Ltd (KOSDAQ:018680)
South Korea · Delayed Price · Currency is KRW 1,870.00
-2.00 (-0.11%)
At close: Oct 23, 2026
Seoul Pharma Market Cap
Seoul Pharma has a market cap or net worth of 21.8 billion as of October 23, 2026. It is the 38,206th most valuable company in the world and the 2,364th biggest in South Korea. Its market cap has decreased by 41.19% in one year.
Market Cap
21.80B
Enterprise Value
20.04B
Revenue
51.08B
Global Rank
Country Rank
#2,364 South Korea
PE Ratio
12.54
ChartMarket Cap Chart
Since March 1, 2001, Seoul Pharma's market cap has increased from 20.00B to 21.80B, an increase of 9.01%. That is a compound annual growth rate of 0.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 21.80B | -39.29% |
| Dec 30, 2025 | 35.91B | -6.95% |
| Dec 30, 2024 | 38.59B | -13.58% |
| Dec 28, 2023 | 44.66B | -23.86% |
| Dec 29, 2022 | 58.65B | -12.36% |
| Dec 30, 2021 | 66.92B | -28.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Korean Drug | 33.72B |
| Korea Arlico Pharm | 32.65B |
| HLscience | 28.16B |
| Pharmsville | 26.70B |
| Baskhanbio Pharma | 23.20B |
| BIFIDO | 21.68B |
| Daesung Microbiological Labs. | 21.55B |
| Union Korea Pharm | 19.70B |